23815-91-0 Usage
Uses
Used in Pharmaceutical and Medical Device Development:
H-ARG-PRO-PRO-OH SULFATE SALT is used as a research compound for the development of pharmaceuticals and medical devices, due to its potential therapeutic applications in wound healing and skin regeneration.
Used in Wound Healing Applications:
H-ARG-PRO-PRO-OH SULFATE SALT is used as a therapeutic agent for promoting wound healing, as it plays a role in tissue repair and regeneration, which can be beneficial in the treatment of various types of wounds.
Used in Skin Regeneration Applications:
H-ARG-PRO-PRO-OH SULFATE SALT is used as a skin regeneration agent, as it has the potential to stimulate the growth and repair of skin tissue, making it useful in the treatment of skin injuries and conditions that require skin repair.
Used in Biotechnology Research:
H-ARG-PRO-PRO-OH SULFATE SALT is used as a research tool in biotechnology to study its effects on tissue regeneration and wound healing, as well as to explore its potential applications in other areas of medical research.
Check Digit Verification of cas no
The CAS Registry Mumber 23815-91-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,8,1 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 23815-91:
(7*2)+(6*3)+(5*8)+(4*1)+(3*5)+(2*9)+(1*1)=110
110 % 10 = 0
So 23815-91-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H28N6O4/c17-10(4-1-7-20-16(18)19)13(23)21-8-2-5-11(21)14(24)22-9-3-6-12(22)15(25)26/h10-12H,1-9,17H2,(H,25,26)(H4,18,19,20)/t10-,11-,12-/m0/s1
23815-91-0Relevant academic research and scientific papers
Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
-
Page/Page column 9, (2008/06/13)
The invention relates to synthetic peptide analogs of D-Arg-Oic-Pro-Gly-Phe and methods of their use to inhibit human platelet aggregation, thrombosis and cell activation mediated by PAR1 and PAR4.
